EULAR and BMJ announce change of ownership of leading rheumatology journals, Annals of the Rheumatic Diseases and RMD Open  

EULAR and BMJ are announcing a change to their longstanding joint ownership of the prestigious medical journals Annals of Rheumatic Diseases (ARD)  and RMD Open. As part of this transition, EULAR will take full ownership of ARD, while BMJ will wholly own RMD Open. ​   BMJ will continue to publish and distribute both journals, while EULAR will exclusively focus on the development of ARD. BMJ will focus on the development of RMD Open as part of its growing portfolio of open access journal titles. This change marks the beginning of an exciting new chapter in the journals’ histories, which will remain focused on advancing rheumatology research and care.

Read more

World Arthritis Day 2023

World Arthritis Day 2023 aims to build upon last year’s campaign about rheumatology being an invisible specialisation of medicine. To provide more insight, EULAR's WAD 2023 campaign is focused on highlighting the lifetime journey of a person with an RMD, from being a child and paediatric patient to living with the disease as an adult, including its impact on all aspects of life, like growing-up, working, caring for others, or ageing. It will also highlight the role rheumatologists (both paediatric and adult) and diverse healthcare professionals in rheumatology (HPR) play in lifelong treatment.

Read more

EULAR Strategy 2024 - 2028

EULAR has launched its new EULAR Strategy 2024 - 2028: Embracing a profound vision for a world where all rheumatic and musculoskeletal diseases (RMDs) are acknowledged, diagnosed and ultimately prevented or cured. 
This transformative strategy centres on EULAR's mission to reduce the impact of RMDs on individuals and societies alike by fostering education, awareness, optimal clinical care, prevention, and cutting-edge research in the field of RMDs. EULAR aims to pave the way towards effective global solutions for managing these conditions.

Read more

EULAR Press Releases

The latest: 

  • Updated: RA Treatment Recommendations
  • Updated: RA Treatment Recommendations
  • Revised: ACR/EULAR Remission Criteria


Read more

EULAR Announces Measures to Support Ukraine 

EULAR has taken a series of decisions in view of Russia’s government attack on Ukraine

The European Alliance of Associations for Rheumatology, EULAR, strongly dissents Russia’s government attack on Ukraine, in violation of Ukraine’s sovereignty, territorial integrity, independence, and the welfare of its residents. As hospitals are being attacked and access to medical aid is interrupted, EULAR wants to respond to this humanitarian crisis and particularly support the Ukrainian people with rheumatic and musculoskeletal diseases (RMDs), who need urgent treatment and assistance.

Read more 

EULAR Recommendations

Read the latest:

  • EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
  • EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis